학술논문

Once-weekly semaglutide reduces the risk of cardiovascular events in people with type 2 diabetes and polyvascular disease: A post hoc analysis
Document Type
Journal
Source
DIABETES OBESITY & METABOLISM; DEC 11 2023, 4p.
Subject
Language
English
ISSN
14631326